enoximone has been researched along with Innate Inflammatory Response in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J | 1 |
Boldt, J; Brosch, C; Lehmann, A; Piper, SN; Suttner, S; Werling, C | 1 |
Boldt, J; Brosch, C; Isgro, F; Lehmann, A; Suttner, S | 1 |
2 trial(s) available for enoximone and Innate Inflammatory Response
Article | Year |
---|---|
Prophylactic use of the phospodiesterase III inhibitor enoximone in elderly cardiac surgery patients: effect on hemodynamics, inflammation, and markers of organ function.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aged; Aged, 80 and over; Biomarkers; Cardiopulmonary Bypass; Cyclic Nucleotide Phosphodiesterases, Type 3; Enoximone; Female; Germany; Hemodynamics; Humans; Inflammation; Male; Phosphodiesterase Inhibitors; Placebos; Prospective Studies | 2002 |
The prophylactic use of the beta-blocker esmolol in combination with phosphodiesterase III inhibitor enoximone in elderly cardiac surgery patients.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Antagonists; Aged; Biomarkers; Blood Gas Analysis; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cyclic Nucleotide Phosphodiesterases, Type 3; Endothelium, Vascular; Enoximone; Female; Glutathione Transferase; Heart Rate; Hemodynamics; Humans; Inflammation; Kidney Function Tests; Male; Monitoring, Intraoperative; Myocardial Ischemia; Phosphodiesterase Inhibitors; Postoperative Complications; Propanolamines; Splanchnic Circulation | 2004 |
1 other study(ies) available for enoximone and Innate Inflammatory Response
Article | Year |
---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature | 2010 |